We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+7.8%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.8B
AUM Growth
+$2.96B
(+8.3%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
12.28%
Holding
2,861
New
368
Increased
965
Reduced
1,202
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$401M |
| 2 |
Netflix
NFLX
|
+$388M |
| 3 |
Ford
F
|
+$340M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$330M |
| 5 |
Boeing
BA
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$391M |
| 2 |
TSMC
TSM
|
+$387M |
| 3 |
Oracle
ORCL
|
+$282M |
| 4 |
Advanced Micro Devices
AMD
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$247M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.93% |
| 2 | Healthcare | 17.44% |
| 3 | Industrials | 12.95% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Financials | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXPR
2401
DELISTED
Express, Inc.
EXPR
| $83.2K | ﹤0.01% |
5,275
-6,654
| -56% | -$134K |
|
|
SPRB
2402
Spruce Biosciences
SPRB
$114M
| $83.1K | ﹤0.01% |
+501
| New | +$93.1K |
|
|
AHT
2403
Ashford Hospitality Trust
AHT
$20.9M
| $81.9K | ﹤0.01% |
2,550
-40
| -2% | -$2K |
|
|
WIMI
2404
WiMi Hologram Cloud
WIMI
$21M
| $81.6K | ﹤0.01% |
7,560
+930
| +14% | +$11.3K |
|
2405
Prospect Capital
PSEC
$1.12B
| $81.4K | ﹤0.01% |
11,700
-383,500
| -97% | -$2.79M |
|
|
CDTX
2406
DELISTED
Cidara Therapeutics
CDTX
| $80.8K | ﹤0.01% |
3,180
+1,890
| +147% | +$53.6K |
|
2407
GeneDx Holdings
WGS
$1.84B
| $80.2K | ﹤0.01% |
6,655
+4,543
| +215% | +$60.6K |
|
2408
Newmark Group
NMRK
$2.88B
| $80.1K | ﹤0.01% |
+11,314
| New | +$90.7K |
|
|
AIV
2409
Aimco
AIV
$375M
| $80K | ﹤0.01% |
10,400
-219,100
| -95% | -$1.63M |
|
2410
Ultrapar
UGP
$6.74B
| $79.4K | ﹤0.01% |
+29,100
| New | +$73.5K |
|
2411
Stem
STEM
$47.7M
| $78.8K | ﹤0.01% |
+695
| New | +$118K |
|
|
WE
2412
DELISTED
WeWork Inc.
WE
| $78.4K | ﹤0.01% |
2,520
+25
| +1% | +$1.36K |
|
|
VCSA
2413
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $77.6K | ﹤0.01% |
4,030
+65
| +2% | +$1.82K |
|
|
AUD
2414
DELISTED
Audacy, Inc.
AUD
| $77K | ﹤0.01% |
571,967
-78,800
| -12% | -$18.1K |
|
2415
Genius Sports
GENI
$1.95B
| $75.7K | ﹤0.01% |
+15,200
| New | +$71.3K |
|
|
PLM
2416
DELISTED
PolyMet Mining Corp.
PLM
| $75.3K | ﹤0.01% |
35,010
-38,200
| -52% | -$94.9K |
|
|
NVTA
2417
DELISTED
Invitae Corporation
NVTA
| $74K | ﹤0.01% |
+54,800
| New | +$108K |
|
|
CTHR
2418
DELISTED
Charles & Colvard Ltd
CTHR
| $73.5K | ﹤0.01% |
7,908
-342
| -4% | -$3.11K |
|
2419
Gaia
GAIA
$47.6M
| $70.6K | ﹤0.01% |
25,400
-2,400
| -9% | -$7.27K |
|
2420
SIGA Technologies
SIGA
$240M
| $69.6K | ﹤0.01% |
12,100
-237,800
| -95% | -$1.59M |
|
2421
Aligos Therapeutics
ALGS
$26.3M
| $68.3K | ﹤0.01% |
3,128
-172
| -5% | -$6.57K |
|
2422
Arteris
AIP
$1.34B
| $66K | ﹤0.01% |
+15,600
| New | +$81.6K |
|
2423
Forte Biosciences
FBRX
$1.57B
| $65.9K | ﹤0.01% |
2,612
-224
| -8% | -$5.63K |
|
2424
Standard BioTools
LAB
$311M
| $65.9K | ﹤0.01% |
33,800
-5,200
| -13% | -$10.3K |
|
2425
Palladyne AI
PDYN
$239M
| $65.6K | ﹤0.01% |
23,033
+1,983
| +9% | +$6.93K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, Two Sigma Advisers held 2,861 positions worth $38.8B, up 8.3% from $35.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Two Sigma Advisers's Q1 2023 filing shows 368 new, 965 increased, 1,202 reduced and 293 closed positions. Its largest new stake was Netflix: 11,730,000 shares worth $405M. The largest sale was Tesla, an estimated $391M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
- Two Sigma Advisers's largest Q1 2023 buy was Netflix: 11,730,000 shares worth $405M.
- Two Sigma Advisers added most to CVS Health in Q1 2023, an estimated $401M increase.
- Two Sigma Advisers's biggest Q1 2023 reduction was TSMC, cutting an estimated $387M.
- Two Sigma Advisers fully exited Tesla in Q1 2023, selling an estimated $391M.
- Two Sigma Advisers's ten largest holdings make up 12% of its $38.8B portfolio in Q1 2023.
- Two Sigma Advisers opened 368 new positions and closed 293 in Q1 2023.
- Two Sigma Advisers's portfolio value rose 8.3% quarter-over-quarter to $38.8B.
Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.